What We're Reading: Page 12
Industry reads hand-picked by our editors
Feb 03, 2026
Feb 02, 2026
Jan 30, 2026
Jan 29, 2026
Jan 28, 2026
-
MIT Technology Review
The first human test of a rejuvenation method will begin “shortly”
-
Reuters
US conditions funding to global vaccine group on dropping mercury-based preservative from shots
-
The Wall Street Journal
Here’s What Happens When You Stop Taking Ozempic and Wegovy
Jan 27, 2026
-
The Boston Globe
‘I’m starting to worry about Massachusetts’: Is Boston’s tech and innovation scene withering?
-
NBC News
Dozens of CDC databases are not being updated — most related to vaccines, study finds
-
The New York Times
William H. Foege, Key Figure in the Eradication of Smallpox, Dies at 89
-
San Francisco Business Times
Biotech’s big J.P. Morgan conference locks into San Francisco for 3 more years
Jan 26, 2026
-
The Wall Street Journal
Merck No Longer in Talks to Buy Revolution Medicines
-
Bloomberg
Llamas Are Big Pharma’s Secret Weapon to Find New Drugs
-
Fierce Biotech
‘Things are looking up’: British biotechs consider going public after yearslong IPO drought
-
NPR
Here’s how ‘shared decision making’ for childhood vaccines could limit access
Previous
